There have been revolutionary changes since orthopedic implants have been used as a treatment of bone fractures and noninfectious joint arthritis.
There has been an acute increase in the number requiring quality implants which has increased the risk for orthopedic device related infection (ODRI) which has been analyzed to be 1%-2%.Treatment of ODRIs most frequently includes long-term antimicrobial treatment and removal of the implant.
It has been proved that 1 randomized clinical trial indicate that a subset of patients can be successfully treated with retention of the implant. Patients eligible for such a treatment must meet the following criteria: acute infection defined as signs and symptoms lasting <14–28 days, an unambiguous diagnosis based on histopathology and microbiology, a stable implant, and susceptibility of the microorganism to an effective orally available antimicrobial agent.
It has been experienced by orthopedics all over the world that treatment of implant-associated infections without removal of the device is an established option only for selected patients on selected occasions.
It can be concluded that based on the interaction between the micro-organisms, the implant and the host may improve the present approach to the diagnosis and treatment of implant-associated infections.
The treatment modality basically depends on the duration of infection, the stability of the implant and the conditions surrounding the soft tissue
Find Updates on Health at Orthopedic Implants on FaceBook
There has been an acute increase in the number requiring quality implants which has increased the risk for orthopedic device related infection (ODRI) which has been analyzed to be 1%-2%.Treatment of ODRIs most frequently includes long-term antimicrobial treatment and removal of the implant.
It has been proved that 1 randomized clinical trial indicate that a subset of patients can be successfully treated with retention of the implant. Patients eligible for such a treatment must meet the following criteria: acute infection defined as signs and symptoms lasting <14–28 days, an unambiguous diagnosis based on histopathology and microbiology, a stable implant, and susceptibility of the microorganism to an effective orally available antimicrobial agent.
It has been experienced by orthopedics all over the world that treatment of implant-associated infections without removal of the device is an established option only for selected patients on selected occasions.
It can be concluded that based on the interaction between the micro-organisms, the implant and the host may improve the present approach to the diagnosis and treatment of implant-associated infections.
The treatment modality basically depends on the duration of infection, the stability of the implant and the conditions surrounding the soft tissue
Find Updates on Health at Orthopedic Implants on FaceBook
No comments:
Post a Comment